A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort...

Area of Science:

• Biotechnology
• Molecular Biology
• Genomics

Background:

• Biomarker discovery for drug development is challenged by limited tissue availability from biopsies.
• Traditional 'omics' and single-cell transcriptomics lack spatial context, limiting analysis of tissue heterogeneity and cell interactions.
• Current spatial transcriptomics platforms have low throughput and limited transcriptome coverage.

Purpose of the Study:

• To introduce Digital Spatial Profiling (DSP) as an advancement for biomarker analysis in solid tissues.
• To highlight DSP's capability for scalable whole transcriptome and ultrahigh-plex protein analysis from single tissue slides.
• To present best practices guidelines for spatial studies in drug discovery and development.

Main Methods:

• Digital Spatial Profiling (DSP) for whole transcriptome and protein analysis.
• Analysis of distinct tissue compartments and structures on a single slide.
• Development of best practices guidelines by the DSP Scientific Consortium.

Main Results:

• DSP overcomes limitations of traditional methods by enabling comprehensive analysis without sacrificing spatial context.
• DSP allows scalable, high-plex analysis of both RNA and proteins within tissue architecture.
• Advancements in tissue profiling deepen understanding of disease biology and therapeutic targets.

Conclusions:

• DSP significantly enhances biomarker analysis in solid tissues, overcoming previous constraints.
• These advancements are crucial for understanding disease mechanisms and identifying novel therapeutic targets.
• Best practices guidelines aim to standardize and improve the application of spatial biology tools in drug discovery.